In the realms of neurology and dermatology, Parkinson’s disease (PD) and melanoma represent two distinct medical challenges, each formidable in its own right. Yet, recent research reveals a surprising, intricate connection between these seemingly disparate conditions, shedding light on the importance of interdisciplinary vigilance in patient care. This blog post delves into the fascinating relationship… Continue reading Melanoma Meets Parkinson’s
Author: Parkie
Rethinking Neurodegeneration
In the ever-evolving field of neurodegenerative disease research, a groundbreaking study has shifted the scientific community’s perspective on the underlying causes of conditions like Parkinson’s and Alzheimer’s. Traditionally, the accumulation of protein aggregates in the brain was believed to be the direct cause of cell death. However, new insights suggest that the real culprit may… Continue reading Rethinking Neurodegeneration
YOPN: A Beacon of Hope
In the landscape of Parkinson’s Disease (PD), particularly Young Onset Parkinson’s Disease (YOPD), the importance of community, resources, and support cannot be overstated. The Young Onset Parkinson’s Network (YOPN) emerges as a pivotal entity in this context, offering a sanctuary where individuals navigating the early stages of PD can find camaraderie, understanding, and invaluable guidance.… Continue reading YOPN: A Beacon of Hope
Metformin and Parkinson’s: A Closer Look
Parkinson’s disease (PD), a neurodegenerative disorder that affects millions worldwide, has long been the focus of extensive research aiming to find effective treatments and therapies. Among the myriad of treatments explored, one unlikely candidate has emerged from the realm of diabetes care: Metformin. This blog post delves deep into the potential of Metformin as a… Continue reading Metformin and Parkinson’s: A Closer Look
Managing Peak Dyskinesia
Welcome to the Parkies Unite blog, where we delve into the complexities of Parkinson’s disease with the aim of shedding light on the nuances of its management, particularly when it comes to medication-induced side effects such as peak dose dyskinesia. This condition represents a significant challenge for many living with Parkinson’s, but understanding its intricacies… Continue reading Managing Peak Dyskinesia